// App-Quantinova.ai

1581.0 : Using sequential next-generation sequencing assays to identify germline cancer predisposition variants.

Researchers

Presenter

  • Ira Lignugaris Kraft

Principal Investigators

  • Amy M. Trottier

  • George F. Steinhardt

  • Nifang Niu

  • Pankhuri Wanjari

  • Wenjun Chen

  • Jeremy Segal

  • Lucy A. Godley

Medical Centers

  • The University of Chicago Medical Center, Chicago, IL

  • Dalhousie University, Halifax, Nova Scotia, Canada.

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A